Coherus Oncology, Inc.
CHRS
$1.42
$0.000.00%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 102.70% | 36.62% | 96.20% | 49.23% | -68.28% |
| Total Receivables | -63.95% | -84.94% | 26.00% | -61.85% | -78.03% |
| Inventory | 37.15% | -24.60% | -95.70% | -92.74% | -94.32% |
| Prepaid Expenses | -48.98% | -23.02% | -32.72% | -19.79% | 5.83% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -33.57% | -39.49% | 24.91% | -31.85% | -50.57% |
|
|
|||||
| Total Current Assets | -33.57% | -39.49% | 24.91% | -31.85% | -50.57% |
| Net Property, Plant & Equipment | -51.51% | -39.41% | -43.90% | -42.80% | -46.13% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -13.90% | -13.81% | -8.89% | -5.67% | -7.22% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 134.78% | -97.62% | -94.35% | -91.33% | -92.44% |
| Total Assets | -28.31% | -42.40% | 2.28% | -34.88% | -51.40% |
|
|
|||||
| Total Accounts Payable | -71.95% | -65.16% | 13.70% | -51.02% | 6.90% |
| Total Accrued Expenses | -69.16% | -72.00% | -59.61% | -49.75% | -36.41% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 5.79% | -35.61% | -52.98% | -57.36% | -98.98% |
| Total Finance Division Other Current Liabilities | 133.74% | 164.00% | 492.70% | -27.14% | -14.35% |
| Total Other Current Liabilities | 133.74% | 164.00% | 492.70% | -27.14% | -14.35% |
| Total Current Liabilities | -48.11% | -50.39% | 25.96% | -43.06% | -52.62% |
|
|
|||||
| Total Current Liabilities | -48.11% | -50.39% | 25.96% | -43.06% | -52.62% |
| Long-Term Debt | -82.53% | -82.54% | -82.67% | -82.77% | -1.61% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -66.57% | -55.66% | -47.93% | -42.23% | -39.02% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 45.16% | 154.15% | 126.01% | 109.57% | -34.64% |
| Total Liabilities | -66.21% | -66.01% | -27.70% | -57.89% | -34.40% |
|
|
|||||
| Common Stock & APIC | 5.32% | 1.75% | 1.47% | 1.72% | 2.10% |
| Retained Earnings | 11.59% | 10.83% | 10.33% | 12.07% | -8.87% |
| Treasury Stock & Other | 2.55% | 29.09% | 26.18% | -1.10% | -1.10% |
| Total Common Equity | 142.85% | 146.23% | 199.77% | 242.47% | -124.17% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 142.85% | 146.23% | 199.77% | 242.47% | -124.17% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 142.85% | 146.23% | 199.77% | 242.47% | -124.17% |
|
|
|||||